Henry Schein Announced $400M Increase to Share Repurchase Plan
Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners, announced today that its Board of Directors has authorized the repurchase of up to $400 million of shares of the Company's common stock.
Barrington Research Maintains Outperform on Henry Schein, Lowers Price Target to $99
Barrington Research analyst Michael Petusky maintains Henry Schein (NASDAQ:HSIC) with a Outperform and lowers the price target from $102 to $99.
COORECTION: Henry Schein Q2 EPS $1.16, Inline
Henry Schein (NASDAQ:HSIC) reported quarterly earnings of $1.16 per share which met the analyst consensus estimate. This is a 4.5 percent increase over earnings of $1.11 per share from the same period last year.
Henry Schein Affirms FY22 Adj. EPS Guidance
Affirms full-year 2022 GAAP diluted EPS guidance range of $4.75 to $4.91, reflecting growth of 7% to 10% over full-year 2021 GAAP diluted EPS and growth
Earnings Scheduled For August 2, 2022
Companies Reporting Before The Bell
• Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.
Analyst Ratings for Henry Schein
Over the past 3 months, 4 analysts have published their opinion on Henry Schein (NASDAQ:HSIC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Goldman Sachs Downgrades Henry Schein to Neutral, Lowers Price Target to $85
Goldman Sachs analyst Nathan Rich downgrades Henry Schein (NASDAQ:HSIC) from Buy to Neutral and lowers the price target from $93 to $85.
Will Chart Analysts Notice Bad Omen on Henry Schein’s Chart
If history is any guide, there may be trouble ahead for shares of Henry Schein (NASDAQ:HSIC). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
Stifel Maintains Hold on Henry Schein, Lowers Price Target to $80
Stifel analyst Jonathan Block maintains Henry Schein (NASDAQ:HSIC) with a Hold and lowers the price target from $90 to $80.